Groundbreaking therapy trialled with BME schizophrenia service users

Press/Media: Research

Release date: 15/9/2017

Description

A study supported by the NIHR has led to improved symptoms and better understanding and communication between Black and minority ethnic (BME) schizophrenia patients, families, and services.

The groundbreaking talking treatment has been developed and successfully trialled in the Culturally-Adapted Family Intervention (CaFI) study, which involved a group of Black and minority ethnic (BME) schizophrenia service users, carers, community members and health professionals.

The study was funded by the NIHR Health Services and Research Delivery programme and supported by the NIHR Clinical Research Network (CRN). Over a period of three years, 24 family units completed 10 therapy sessions at Greater Manchester Mental Health NHS Foundation Trust. 

People of African-Caribbean origin, including those of ‘Mixed’ heritage, are nine times more likely to be diagnosed with schizophrenia than White British people. Black Africans’ risk of diagnosis is six times greater. 

The study was led by Dr Dawn Edge, Senior Lecturer and Academic Lead for Equality, Diversity and Inclusion at the University of Manchester. The study's co-investigators included Professor Kathryn Abel, NIHR CRN National Specialty Lead for Mental Health.

Dr Edge said: “We have demonstrated that it is possible to develop this treatment and to improve African-Caribbean patients’ and families’ engagement with mental health services.”

A video has now been produced about the CaFI study, featuring service users and their families. A summary of the study and its results are also available to read online.

Media contributions

TitleGroundbreaking therapy trialled with BME schizophrenia service users
Degree of recognitionNational
Media name/outletNIHR News
Media typeWeb
CountryUnited Kingdom
Date15/09/17
DescriptionA study supported by the NIHR has led to improved symptoms and better understanding and communication between Black and minority ethnic (BME) schizophrenia patients, families, and services.

The groundbreaking talking treatment has been developed and successfully trialled in the Culturally-Adapted Family Intervention (CaFI) study, which involved a group of Black and minority ethnic (BME) schizophrenia service users, carers, community members and health professionals.

The study was funded by the NIHR Health Services and Research Delivery programme and supported by the NIHR Clinical Research Network (CRN). Over a period of three years, 24 family units completed 10 therapy sessions at Greater Manchester Mental Health NHS Foundation Trust.

People of African-Caribbean origin, including those of ‘Mixed’ heritage, are nine times more likely to be diagnosed with schizophrenia than White British people. Black Africans’ risk of diagnosis is six times greater.

The study was led by Dr Dawn Edge, Senior Lecturer and Academic Lead for Equality, Diversity and Inclusion at the University of Manchester. The study's co-investigators included Professor Kathryn Abel, NIHR CRN National Specialty Lead for Mental Health.

Dr Edge said: “We have demonstrated that it is possible to develop this treatment and to improve African-Caribbean patients’ and families’ engagement with mental health services.”

A video has now been produced about the CaFI study, featuring service users and their families. A summary of the study and its results are also available to read online.
Producer/AuthorNational Institute for Health Research
URLhttps://www.nihr.ac.uk/news/groundbreaking-therapy-trialled-with-bme-schizophrenia-service-users/6909
PersonsDawn Edge